Elad Jacoby
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 62
- CAR-T cell therapy research 62
- Hematology 14
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 2
- Co-authors
- Michal Judith Besser (20 shared papers)Terry J. Fry (10 shared papers)Yinmeng Yang (6 shared papers)Amos Toren (25 shared papers)Jacob Schachter (9 shared papers)Abraham Avigdor (20 shared papers)Amilia Meir (6 shared papers)Christopher Daniel Chien (7 shared papers)
- Journals
- Transplantation and Cellular Therapy (10 papers)Bone Marrow Transplantation (10 papers)Blood (8 papers)Leukemia (5 papers)Pediatric Blood & Cancer (4 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Elad Jacoby
86 papers receiving 4.3k citations
Elad Jacoby's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 2.9k
- Hematology 303
- Genetics 151
- Cancer Research 230
- Immunology 329
Countries citing papers authored by Elad Jacoby
This map shows the geographic impact of Elad Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elad Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elad Jacoby more than expected).
Fields of papers citing papers by Elad Jacoby
This network shows the impact of papers produced by Elad Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elad Jacoby. The network helps show where Elad Jacoby may publish in the future.
Co-authors
The 25 scholars most cited alongside Elad Jacoby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy Hit paper breakdown → | 2015 | 1081 |
| 2 | 2016 | 366 | |
| 3 | 2019 | 320 | |
| 4 | 2020 | 189 | |
| 5 | 2017 | 173 | |
| 6 | 2013 | 170 | |
| 7 | 2019 | 154 | |
| 8 | 2013 | 151 | |
| 9 | 2018 | 107 | |
| 10 | 2018 | 101 | |
| 11 | 2013 | 98 | |
| 12 | 2019 | 96 | |
| 13 | 2015 | 91 | |
| 14 | 2015 | 90 | |
| 15 | 2022 | 75 | |
| 16 | 2019 | 65 | |
| 17 | 2022 | 58 | |
| 18 | 2021 | 57 | |
| 19 | 2022 | 49 | |
| 20 | 2020 | 46 |
About Elad Jacoby
Elad Jacoby is a scholar working on Oncology, Hematology, Public Health, Environmental and Occupational Health, Genetics and Molecular Biology, having authored 94 papers that have together received 4.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (62 papers), Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (10 papers), Mitochondrial Function and Pathology (5 papers), Glioma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Oncology (2.9k citations), Hematology (303 citations), Genetics (151 citations), Cancer Research (230 citations) and Immunology (329 citations). Elad Jacoby has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Michal Judith Besser, Terry J. Fry, Yinmeng Yang, Amos Toren, Jacob Schachter, Abraham Avigdor, Amilia Meir, Christopher Daniel Chien, Arnon Nagler and Avichai Shimoni. Their work appears in journals such as Transplantation and Cellular Therapy, Bone Marrow Transplantation, Blood, Leukemia and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.